MORGANTOWN — Mylan NV saw its first quarter 2019 revenues fall 7% compared to Q1 2018, and its stock share price fall 15 percent compared to the same period. Mylan CEO Heather Bresch said the earnings fell within the expected range and represented a solid start to the year.
State medical cannabis program won't be ready to roll on start date
West Virginias medical cannabis program officially takes effect July 1.
June 23, 2019 - 1:00 am